Adventitial transduction of lentivirus-shRNA-VEGF-A in arteriovenous fistula reduces venous stenosis formation

Kidney International

Volumn 85, Issue 2, 2014, Pages 289-306

  Yang, Binxia ^a   Janardhanan, Rajiv ^a   Vohra, Pawan ^a   Greene, Eddie L ^a   Bhattacharya, Santanu ^a   Withers, Sarah ^a   Roy, Bhaskar ^a   Nieves Torres, Evelyn C ^a   Mandrekar, Jaywant ^a   Leof, Edward B ^a   Mukhopadhyay, Debabrata ^a   Misra, Sanjay ^a  

^a MAYO CLINIC   (United States)

Author keywords

diabetes; vascular access; VEGF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BEVACIZUMAB; CASPASE 3; CREATININE; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITROGEN; SHORT HAIRPIN RNA; UREA; VASCULOTROPIN RECEPTOR 1; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS FISTULA; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; GENE SILENCING; GENETIC TRANSDUCTION; HYPERPLASIA; MALE; MOUSE; MYOFIBROBLAST; NEOINTIMA; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE REGENERATION; UREA NITROGEN BLOOD LEVEL; VENOUS NEOINTIMAL HYPERPLASIA; VENOUS STASIS; VIRAL GENE DELIVERY SYSTEM;

ADVENTITIA; ANIMALS; APOPTOSIS; ARTERIOVENOUS SHUNT, SURGICAL; CAROTID ARTERIES; CASPASE 3; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENETIC THERAPY; GENETIC VECTORS; GRAFT OCCLUSION, VASCULAR; HYPERPLASIA; JUGULAR VEINS; LENTIVIRUS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NEOINTIMA; NEPHRECTOMY; RENAL INSUFFICIENCY, CHRONIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893319095     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.290     Document Type: Article

References (45)

1. Collins AJ, Kasiske B, Herzog C et al. Excerpts from the United States Renal Data System 2003 Annual Data Report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 2003; 42: A5-A7
2. Rooijens PPGM, Tordoir JHM, Stijnen T et al. Radiocephalic wrist arteriovenous fistula for hemodialysis: Meta-Analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg 2004; 28: 583-589
3. Sullivan KL, Besarab A, Bonn J et al. Hemodynamics of failing dialysis grafts. Radiology 1993; 186: 867-872
4. Rekhter M, Nicholls S, Ferguson M et al. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 1993; 13: 609-617
5. Swedberg SH, Brown BG, Sigley R et al. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 1989; 80: 1726-1736
6. Roy-Chaudhury P, Kelly BS, Miller MA et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001; 59: 2325-2334
7. Misra S, Doherty MG, Woodrum D et al. Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 2005; 68: 2890-2900
8. Li L, Terry CM, Blumenthal DK et al. Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant 2007; 22: 3139-3146
9. Wang Y, Krishnamoorthy M, Banerjee R et al. Venous stenosis in a pig arteriovenous fistula model anatomy, mechanisms and cellular phenotypes. Nephrol Dial Transplant 2007; 22: 3139-3146
10. Janardhanan R, Yang B, Vohra P et al. Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model. Kidney Int 2013; 84: 338-352
11. Misra S, Fu A, Rajan D et al. Expression of hypoxia inducible factor-1 alpha, macrophage migration inhibition factor, matrix metalloproteinase-2 and-9, and their inhibitors in hemodialysis grafts and arteriovenous fistulas. J Vasc Interv Radiol 2008; 19: 252-259
12. Misra S, Fu A, Anderson J et al. The rat femoral arteriovenous fistula model: Increased expression of MMP-2 and MMP-9 at the venous stenosis. J Vasc Interv Radiol 2008; 19: 587-594
13. Misra S, Fu AA, Puggioni A et al. Increased shear stress with up regulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts. Am J Physiol Heart Circ Physiol 2008; 294: H2219-H2230
14. Misra S, Shergill U, Yang B et al. Increased expression of HIF-1a, VEGF-A and its receptors, MMP-2, TIMP-1, and ADAMTS-1 at the venous stenosis of arteriovenous fistula in a mouse model with renal insufficiency. J Vasc Interv Radiol 2010; 21: 1255-1261
15. Bhardwaj S, Roy H, Heikura T et al. VEGF-A, VEGF-D and VEGF-D induced intimal hyperplasia in carotid arteries. Eur J Clin Invest 2005; 35: 669-676
16. Di Marco GS, Reuter S, Hillebrand U et al. The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. J Am Soc Nephrol 2009; 20: 2235-2245
17. Hutter R, Carrick FE, Valdiviezo C et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 2004; 110: 2430-2435
18. Inoue M, Itoh H, Ueda M et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108-2116
19. Simons M. VEGF and restenosis: The rest of the story. Arterioscler Thromb Vasc Biol 2009; 29: 439-440
20. Shiojima I, Walsh K. The role of vascular endothelial growth factor in restenosis: The controversy continues. Circulation 2004; 110: 2283-2286
21. Zhao Q, Egashira K, Hiasa K et al. Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury. Arterioscler Thromb Vasc Biol 2004; 24: 2284-2289
22. Ohtani K, Egashira K, Hiasa K-i et al. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation 2004; 110: 2444-2452
23. Yang B, Shergill U, Fu AA et al. The mouse arteriovenous fistula model. J Vasc Interv Radiol 2009; 20: 946-950
24. Misra S, Shergill U, Yang B et al. Increased expression of HIF-1alpha, VEGF-A and its receptors, MMP-2, TIMP-1, and ADAMTS-1 at the venous stenosis of arteriovenous fistula in a mouse model with renal insufficiency. J Vasc Interv Radiol 2010; 21: 1255-1261
25. Shay-Salit A, Shushy M, Wolfovitz E et al. VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc Natl Acad Sci USA 2002; 99: 9462-9467
26. Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1. Circ Res 1998; 83: 832-840
27. Misra S, Fu AA, Misra KD et al. Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: Implications for venous neointimal hyperplasia in hemodialysis access. J Vasc Interv Radiol 2010; 21: 896-902
28. Das M, Burns N, Wilson SJ et al. Hypoxia exposure induces the emergence of fibroblasts lacking replication repressor signals of PKC{zeta} in the pulmonary artery adventitia. Cardiovasc Res 2008; 78: 440-448
29. Misra S, Fu A, Pugionni A et al. Increased expression of hypoxia inducible factor-1a in a porcine model of chronic renal insufficiency with arteriovenous polytetrafluoroethylene grafts. J Vasc Interv Radiol 2008; 19: 260-265
30. Misra S, Bonan R, Pflederer T et al. BRAVO I: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney Int 2006; 70: 2006-2013
31. Haskal ZJ, Trerotola S, Dolmatch B et al. Stent graft versus balloon angioplasty for failing dialysis-Access grafts. N Engl J Med 2010; 362: 494-503
32. Abbruzzese TA, Guzman RJ, Martin RL et al. Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model. Surgery 1998; 124: 328-334
33. Rotmans JI, Velema E, Verhagen HJ et al. Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model. J Vasc Surg 2004; 39: 432-439
34. Wang H, Zhang M, Bianchi M et al. Fetuin (alpha 2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA 1998; 95: 14429-14434
35. Kokubo T, Ishikawa N, Uchida H et al. CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol 2009; 20: 1236-1245
36. Pawlak K, Pawlak D, Mysliwiec M. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients-role of oxidative stress. Cytokine 2005; 31: 18-24
37. Pawlak K, Pawlak D, Mysliwiec M. Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients. Med Sci Monit 2006; 12: CR181-CR185
38. Pawlak K, Pawlak D, Mysliwiec M. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis 2007; 190: 199-204
39. Esposito C, He CJ, Striker GE et al. Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol 1999; 154: 891-897
40. Wang Y, Wang YP, Tay YC et al. Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events. Kidney Int 2000; 58: 1797-1804
41. Bock F, Onderka J, Dietrich T et al. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci 2007; 48: 2545-2552
42. Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources. Government print office: Washington, DC, 1996
43. Turunen MP, Lehtola T, Heinonen SE et al. Efficient regulation of VEGF expression by promoter-Targeted lentiviral shRNAs based on epigenetic mechanism: A novel example of epigenetherapy. Circ Res 2009; 105: 604-609
44. Basu S, Nagy JA, Pal S et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 2001; 7: 569-574
45. Hughes D, Fu AA, Puggioni A et al. Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts alleviates hypoxia and decreases neointimal proliferation through a matrix metalloproteinase-9- mediated pathway-A pilot study. Nephrol Dial Transplant 2009; 24: 85-96